Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice

Objective: to evaluate the efficacy and safety of cladribine tablets as a treatment for immune reconstitution of highly active multiple sclerosis (HAMS) in general clinical practice.Patients and methods. 34 patients with HAMS who were followed up at the Moscow Multiple Sclerosis Center in 2018–2021...

Full description

Bibliographic Details
Main Authors: S. V. Petrov, O. V. Boyko, A. N. Boyko
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-02-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/1743